Astec Lifesciences notifies shareholders about the transfer of unclaimed dividends and shares to the IEPF. Ensure your claims before the deadline.
Astec Lifesciences Notifies Shareholders of IEPF Transfer of Unclaimed Shares and Dividends
Mumbai, May 22, 2025 — Astec Lifesciences Ltd (BSE: 533138) has sent a formal notice to its shareholders in relation to the transfer of unclaimed equity shares and accrued dividends to the Investor Education and Protection Fund (IEPF) as per the Companies Act, 2013.
This statutory disclosure aligns with regulatory norms that aim to protect investor interests while maintaining corporate transparency. The company’s notification, published via BSE India on May 22, 2025, provides crucial information for shareholders who may have unclaimed dividends or inactive demat accounts linked to equity shares held for seven or more consecutive years.
What the Notice Means for Shareholders
More Read
The corporations are bound to transfer unclaimed dividends along with the corresponding shares to the IEPF, as per Section 124(6) of the Companies Act, 2013 and Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, if they remain unclaimed for seven consecutive years.
Astec Lifesciences‘ recent announcement lists clearly affected shareholders, along with timelines for action and guidance on how to recover their shares or dividends prior to final transfer being triggered.
Shareholders who have not been able to claim their dividends after FY 2016–17 are requested to act promptly. After the transfer to IEPF, it will become a lengthy process to recover these funds through the official IEPF portal and authentication by the authority.
Steps for Shareholders to Avoid IEPF Transfer
Astec Lifesciences encourages all shareholders to verify their dividend payment records and update their banking and demat details as soon as possible. Shareholders can:
- Check their dividend history via the company’s website or contact the Registrar and Share Transfer Agent (RTA).
- Claim unpaid dividends by submitting a duly filled Form IEPF-5 online.
- Contact the company’s investor relations desk for personalized assistance and clarification.
Those whose shares are poised for transfer will also receive individual communications by email or post, depending on available contact details.
Shareholder Rights and Reclaim Process
Once the shares and dividends are transferred to IEPF, shareholders can reclaim their investments, but it involves filing a claim with the IEPF Authority. The process includes submitting the IEPF-5 form, supporting documents like identity proof, and a request letter, all of which must be validated by the company before IEPF processing.
While this recovery process is fully supported by the government, it is time-consuming and often delayed due to document mismatches or verification bottlenecks. Hence, timely action now is highly advisable.
Corporate Responsibility and Regulatory Compliance
Astec Lifesciences‘ advance disclosure reflects its dedication to transparency and investor interaction. The company has placed the notice in the public domain and has encouraged interested investors to contact it prior to the statutory transfer taking place.
In line with good governance practices, the full notice and shareholder list are available on the company’s official page on BSE India.
About Astec Lifesciences Ltd
Astec Lifesciences Ltd is a market leader in the agrochemical sector, excelling in fungicides, herbicides, and API. Having come into existence as a subsidiary firm of the Godrej Group, it serves both the domestic and international markets with keen emphasis on innovation, sustainability, and regulatory compliance.
